InflaRx to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
JENA, Germany, Sept. 09, 2021 (GLOBE NEWSWIRE) -- InflaRx (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announces that Prof. Niels C. Riedemann, Chief Executive Officer and Founder, will present a company overview at the H.C. Wainwright 23rd Annual Global Investment Conference, which is being held virtually. The presentation will be available on demand starting at 7:00 AM EDT / 1:00 PM CET on Monday, September 13, 2021.
A webcast of the event will be available for 90 days on the InflaRx website in the Investors section under Events & Presentations.
About InflaRx N.V.:
MC Services AG
Augmented and Virtual Reality: Redefining the Future of Work
The Need for Speed: How Fast can 6G Transmit?
Cannabis and the Cash Ecosystem